Oncologists in northern England rarely prescribe prophylaxis for venous thromboembolism (VTE) among patients undergoing cancer treatment

Author：

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1405, 2003-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Cost-Effectiveness Analysis of Fondaparinux Sodium Compared with Enoxaparin Sodium as Prophylaxis Against Venous Thromboembolism: Use in Patients Undergoing Major Orthopaedic Surgery

By Sullivan S.D.

PharmacoEconomics, Vol. 22, Iss. 9, 2004-01 ,pp. : 605-620

Adis International

Access to resources Recommend Favorite

Dermatan Sulfate versus Unfractionated Heparin for the Prevention of Venous Thromboembolism in Patients Undergoing Surgery for Cancer: A Cost-Effectiveness Analysis

By Attanasio E.

PharmacoEconomics, Vol. 19, Iss. 1, 2001-01 ,pp. : 57-68

Adis International

Access to resources Recommend Favorite

Treatment of thromboembolism in cancer patients

By Panova-Noeva Marina Falanga Anna

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 12, 2010-08 ,pp. : 2049-2058

Informa Healthcare

Access to resources Recommend Favorite

Long-Term Therapy of Venous Thromboembolism in Cancer Patients

By Streiff Michael B.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 9, 2006-10 ,pp. : 903-910

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

New guidelines for VTE prevention/treatment in cancer patients

Inpharma, Vol. 1, Iss. 1616, 2007-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite